| Kawasaki disease shock syndrome: clinical characteristics and possible use of IL- IL-10 and IFN- as biomarkers for early recognition |
19 |
| Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome |
19 |
| Amendment of the OMERACT ultrasound definitions of joints' features in healthy children when using the DOPPLER technique |
16 |
| Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what? |
16 |
| Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting |
14 |
| Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate |
12 |
| Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy |
11 |
| Different histological classifications for Henoch-Schonlein purpura nephritis: which one should be used? |
10 |
| Incidence and risk factors for recurrent Henoch-Schonlein purpura in children from a 16-year nationwide database |
10 |
| Reliability of ultrasonography to detect inflammatory lesions and structural damage in juvenile idiopathic arthritis |
9 |
| Chronic non-bacterial osteomyelitis: a comparative study between children and adults |
9 |
| Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents |
8 |
| Improvement of medication adherence in adolescents and young adults with SLE using web-based education with and without a social media intervention, a pilot study |
8 |
| Chronic non bacterial osteitis- a multicentre study |
7 |
| Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany |
7 |
| Kawasaki disease: abnormal initial echocardiogram is associated with resistance to IV Ig and development of coronary artery lesions |
7 |
| The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey |
6 |
| Orofacial symptoms and oral health-related quality of life in juvenile idiopathic arthritis: a two-year prospective observational study |
6 |
| Pediatric Rheumatology Collaborative Study Group - over four decades of pivotal clinical drug research in pediatric rheumatology |
6 |
| Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature |
6 |
| Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre |
6 |
| Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases |
6 |
| The effects of TNF-alpha inhibitor therapy on the incidence of infection in JIA children: a meta-analysis |
5 |
| Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome |
5 |
| Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab |
5 |
| Feasibility of a musculoskeletal ultrasound intervention to improve adherence in juvenile idiopathic arthritis: a proof-of concept trial |
5 |
| Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study |
5 |
| Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ) |
5 |
| Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC) |
5 |
| A wearable activity tracker intervention for promoting physical activity in adolescents with juvenile idiopathic arthritis: a pilot study |
5 |
| Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children |
4 |
| Arterial properties in adults with long-lasting active juvenile idiopathic arthritis compared to healthy controls |
4 |
| Disease burden and social impact of pediatric chronic nonbacterial osteomyelitis from the patient and family perspective |
4 |
| Vitamin D and juvenile idiopathic arthritis |
4 |
| The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients |
4 |
| Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management |
4 |
| Dutch juvenile idiopathic arthritis patients, carers and clinicians create a research agenda together following the James Lind Alliance method: a study protocol |
4 |
| An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA) |
4 |
| Living with autoinflammatory diseases: identifying unmet needs of children, adolescents and adults |
4 |
| Towards a new set of classification criteria for PFAPA syndrome |
4 |
| Frequency of CD19(+)CD24(hi)Cd38(hi) regulatory B cells is decreased in peripheral blood and synovial fluid of patients with juvenile idiopathic arthritis: a preliminary study |
4 |
| Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis |
3 |
| Being on the juvenile dermatomyositis rollercoaster: a qualitative study |
3 |
| Successful implementation of a clinical transition pathway for adolescents with juvenile-onset rheumatic and musculoskeletal diseases |
3 |
| IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry) |
3 |
| Psychological characteristics of caregivers of pediatric patients with chronic rheumatic disease in relation to treatment adherence |
3 |
| Pediatric systemic lupus erythematosus patients in South Africa have high prevalence and severity of cardiac and vascular manifestations |
3 |
| Pediatric anti-NMDA receptor encephalitis with catatonia: treatment with electroconvulsive therapy |
3 |
| Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria |
3 |
| Educational initiatives and training for paediatric rheumatology in Europe |
3 |
